Gene · 6590
Papers3,867
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
881 to 900 of 3,867
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Transcriptional analysis identifies potential novel biomarkers associated with successful ex-vivo perfusion of human donor lungs. | Clin Transplant | 2022 | 34954872 | PubTator, text mining | PubMed |
| Elevation of activated neutrophils in chronic rhinosinusitis with nasal polyps. | J Allergy Clin Immunol | 2022 | 34953792 | PubTator, text mining | PubMed |
| Utilizing the Potential of Antimicrobial Peptide LL-37 for Combating SARS-COV- 2 Viral Load in Saliva: an In Silico Analysis. | Eur J Dent | 2022 | 34937110 | PubTator, text mining | PubMed |
| Translational implications of Th17-skewed inflammation due to genetic deficiency of a cadherin stress sensor. | J Clin Invest | 2022 | 34905516 | PubTator, text mining | PubMed |
| Grouped-seq for integrated phenotypic and transcriptomic screening of patient-derived tumor organoids. | Nucleic Acids Res | 2022 | 34893868 | PubTator, text mining | PubMed |
| Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata. | J Antimicrob Chemother | 2022 | 34893830 | PubTator, text mining | PubMed |
| SPINK6 inhibits human airway serine proteases and restricts influenza virus activation. | EMBO Mol Med | 2022 | 34826211 | PubTator, text mining | PubMed |
| Nasal immune gene expression in response to azelastine and fluticasone propionate combination or monotherapy. | Immun Inflamm Dis | 2022 | 34813682 | PubTator, text mining | PubMed |
| Atypical response to bacterial coinfection and persistent neutrophilic bronchoalveolar inflammation distinguish critical COVID-19 from influenza. | JCI Insight | 2022 | 34793331 | PubTator, text mining | PubMed |
| Categorizing Sequences of Concern by Function To Better Assess Mechanisms of Microbial Pathogenesis. | Infect Immun | 2022 | 34780277 | PubTator, text mining | PubMed |
| Nuclear accumulation of KPNA2 impacts radioresistance through positive regulation of the PLSCR1-STAT1 loop in lung adenocarcinoma. | Cancer Sci | 2022 | 34773335 | PubTator, text mining | PubMed |
| Skin aging: Dermal adipocytes metabolically reprogram dermal fibroblasts. | Bioessays | 2022 | 34766637 | PubTator, text mining | PubMed |
| Insights into the molecular landscape of osteoarthritis in human tissues. | Curr Opin Rheumatol | 2022 | 34750308 | PubTator, text mining | PubMed |
| Profiling the specificity of clonally expanded plasma cells during chronic viral infection by single-cell analysis. | Eur J Immunol | 2022 | 34727578 | PubTator, text mining | PubMed |
| Primary cutaneous anaplastic large-cell lymphoma with aberrant cytokeratin expression: An unusual mimicker of poorly differentiated carcinomas. | J Cutan Pathol | 2022 | 34705295 | PubTator, text mining | PubMed |
| Pleomorphic Onychomatricoma: A Mimicker of Malignancy. | Acta Derm Venereol | 2022 | 34694416 | PubTator, text mining | PubMed |
| High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas. | Head Neck | 2022 | 34693597 | PubTator, text mining | PubMed |
| Clinicopathological features and resistance mechanisms in HIP1-ALK-rearranged lung cancer: A multicenter study. | Genes Chromosomes Cancer | 2022 | 34687488 | PubTator, text mining | PubMed |
| F-circEA1 regulates cell proliferation and apoptosis through ALK downstream signaling pathway in non-small cell lung cancer. | Hum Cell | 2022 | 34633654 | PubTator, text mining | PubMed |
| Primary cutaneous anaplastic large-cell lymphoma with DUSP22-IRF4 rearrangement following insect bites. | J Cutan Pathol | 2022 | 34622970 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6590/papers?page=45